edoc

Items where Author is "Bardonneau, C."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2022 | 2021
Number of items: 2.

2022

Kande Betu Kumesu, V. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Nganzobo Ngima, P. and Mahenzi Mbembo, H. and Fina Lubaki, J. P. and Lumeya Vuvu, S. and Kuziena Mindele, W. and Ilunga Wa Kyhi, M. and Mandula Mokenge, G. and Kaninda Badibabi, L. and Kasongo Bonama, A. and Kavunga Lukula, P. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2022) Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial. Lancet Glob Health, 10 (11). e1665-e1674.

2021

Mesu, V. K. B. K. and Mutombo Kalonji, W. and Bardonneau, C. and Valverde Mordt, O. and Ngolo Tete, D. and Blesson, S. and Simon, F. and Delhomme, S. and Bernhard, S. and Mahenzi Mbembo, H. and Mpia Moke, C. and Lumeya Vuvu, S. and Mudji E'kitiak, J. and Akwaso Masa, F. and Mukendi Ilunga, M. and Mpoyi Muamba Nzambi, D. and Mayala Malu, T. and Kapongo Tshilumbwa, S. and Botalema Bolengi, F. and Nkieri Matsho, M. and Lumbala, C. and Scherrer, B. and Strub-Wourgaft, N. and Tarral, A.. (2021) Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health, 9 (7). e999-e1008.

This list was generated on Fri Mar 29 01:15:34 2024 CET.